{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:47:42Z","timestamp":1772815662995,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Health and Medical Research Council (Australia) Investigator Grant","award":["GNT2007912"],"award-info":[{"award-number":["GNT2007912"]}]},{"name":"NHMRC-AMED Dementia Collaborative Research Grant","award":["GNT2022203"],"award-info":[{"award-number":["GNT2022203"]}]},{"name":"Alzheimer\u2019s Association USA","award":["23AARF-1020292"],"award-info":[{"award-number":["23AARF-1020292"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01948-8","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T13:55:28Z","timestamp":1770213328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex and APOE \u03b54 genotype modify risk factor associations with cerebral amyloid angiopathy: a multi-cohort autopsy study"],"prefix":"10.1186","volume":"18","author":[{"given":"Liwei","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Goudey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"1948_CR1","volume-title":"Cerebral amyloid angiopathy","author":"J Kuhn","year":"2024","unstructured":"Kuhn J, Sharman T. Cerebral amyloid angiopathy. Treasure Island (FL): StatPearls; 2024."},{"key":"1948_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","volume":"7","author":"A Biffi","year":"2011","unstructured":"Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol. 2011;7:1\u20139.","journal-title":"J Clin Neurol"},{"key":"1948_CR3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","volume":"21","author":"A Charidimou","year":"2022","unstructured":"Charidimou A, Boulouis G, Frosch MP, Baron JC, Pasi M, Albucher JF, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022;21:714\u201325.","journal-title":"Lancet Neurol"},{"key":"1948_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.jacc.2017.07.724","volume":"70","author":"CV DeSimone","year":"2017","unstructured":"DeSimone CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, Asirvatham SJ, Holmes DR Jr. Cerebral amyloid angiopathy: diagnosis, clinical implications, and management strategies in atrial fibrillation. J Am Coll Cardiol. 2017;70:1173\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"1948_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2214\/AJR.22.28461","volume":"220","author":"M Roytman","year":"2023","unstructured":"Roytman M, Mashriqi F, Al-Tawil K, Schulz PE, Zaharchuk G, Benzinger TLS, et al. Amyloid-related imaging abnormalities: an update. AJR Am J Roentgenol. 2023;220:562\u201374.","journal-title":"AJR Am J Roentgenol"},{"key":"1948_CR6","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1093\/brain\/awad188","volume":"146","author":"H Hampel","year":"2023","unstructured":"Hampel H, Elhage A, Cho M, Apostolova LG, Nicoll JAR, Atri A. Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics. Brain. 2023;146:4414\u201324.","journal-title":"Brain"},{"key":"1948_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"1948_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13024-023-00637-0","volume":"18","author":"VK Ramanan","year":"2023","unstructured":"Ramanan VK, Day GS. Anti-amyloid therapies for Alzheimer disease: finally, good news for patients. Mol Neurodegener. 2023;18:42.","journal-title":"Mol Neurodegener"},{"key":"1948_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2018.12.030","volume":"1710","author":"LS Robison","year":"2019","unstructured":"Robison LS, Gannon OJ, Salinero AE, Zuloaga KL. Contributions of sex to cerebrovascular function and pathology. Brain Res. 2019;1710:43\u201360.","journal-title":"Brain Res"},{"key":"1948_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/01.HYP.0000172945.06681.a4","volume":"46","author":"RA Khalil","year":"2005","unstructured":"Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension. 2005;46:249\u201354.","journal-title":"Hypertension"},{"key":"1948_CR11","doi-asserted-by":"publisher","first-page":"R233","DOI":"10.1152\/ajpregu.00338.2003","volume":"286","author":"JM Orshal","year":"2004","unstructured":"Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol. 2004;286:R233-249.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1948_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13293-020-00309-4","volume":"11","author":"C Abi-Ghanem","year":"2020","unstructured":"Abi-Ghanem C, Robison LS, Zuloaga KL. Androgens\u2019 effects on cerebrovascular function in health and disease. Biol Sex Differ. 2020;11:35.","journal-title":"Biol Sex Differ"},{"key":"1948_CR13","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, Schneider JA. Religious orders study and Rush memory and aging project. J Alzheimers Dis. 2018;64:S161\u201389.","journal-title":"J Alzheimers Dis"},{"key":"1948_CR14","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2174\/156720512801322627","volume":"9","author":"LL Barnes","year":"2012","unstructured":"Barnes LL, Shah RC, Aggarwal NT, Bennett DA, Schneider JA. The minority aging research study: ongoing efforts to obtain brain donation in African Americans without dementia. Curr Alzheimer Res. 2012;9:734\u201345.","journal-title":"Curr Alzheimer Res"},{"key":"1948_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.sleh.2023.08.008","volume":"9","author":"AL Tapia","year":"2023","unstructured":"Tapia AL, Yu L, Lim A, Barnes LL, Hall MH, Butters MA, et al. Race and sex differences in the longitudinal changes in multidimensional self-reported sleep health characteristics in aging older adults. Sleep Health. 2023;9:947\u201358.","journal-title":"Sleep Health"},{"key":"1948_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296.","journal-title":"PLoS Med"},{"key":"1948_CR17","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","volume":"85","author":"PA Boyle","year":"2015","unstructured":"Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, et al. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015;85:1930\u20136.","journal-title":"Neurology"},{"key":"1948_CR18","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1212\/WNL.0000000000001935","volume":"85","author":"RS Wilson","year":"2015","unstructured":"Wilson RS, Boyle PA, Yu L, Barnes LL, Sytsma J, Buchman AS, et al. Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology. 2015;85:984\u201391.","journal-title":"Neurology"},{"key":"1948_CR19","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1161\/STROKEAHA.111.623462","volume":"42","author":"AS Buchman","year":"2011","unstructured":"Buchman AS, Leurgans SE, Nag S, Bennett DA, Schneider JA. Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke. 2011;42:3183\u20139.","journal-title":"Stroke"},{"key":"1948_CR20","doi-asserted-by":"publisher","first-page":"e1976","DOI":"10.1212\/WNL.0000000000200182","volume":"98","author":"S Oveisgharan","year":"2022","unstructured":"Oveisgharan S, Yu L, Barnes LL, Agrawal S, Schneider JA, Bennett DA, et al. Association of statins with cerebral atherosclerosis and incident Parkinsonism in older adults. Neurology. 2022;98:e1976\u201384.","journal-title":"Neurology"},{"key":"1948_CR21","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1161\/STROKEAHA.120.030226","volume":"52","author":"S Oveisgharan","year":"2021","unstructured":"Oveisgharan S, Yu L, Capuano A, Arvanitakis Z, Barnes LL, Schneider JA, et al. Late-life vascular risk score in association with postmortem cerebrovascular disease brain pathologies. Stroke. 2021;52:2060\u20137.","journal-title":"Stroke"},{"key":"1948_CR22","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/STROKEAHA.110.595082","volume":"42","author":"Z Arvanitakis","year":"2011","unstructured":"Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011;42:722\u20137.","journal-title":"Stroke"},{"key":"1948_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National institute on aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 2012;8:1\u201313.","journal-title":"Alzheimers Dement"},{"key":"1948_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/jnen\/nlad086","volume":"82","author":"A Kapasi","year":"2023","unstructured":"Kapasi A, Poirier J, Hedayat A, Scherlek A, Mondal S, Wu T, et al. High-throughput digital quantification of Alzheimer disease pathology and associated infrastructure in large autopsy studies. J Neuropathol Exp Neurol. 2023;82:976\u201386.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1948_CR25","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1016\/j.neurobiolaging.2015.06.028","volume":"36","author":"WD Brenowitz","year":"2015","unstructured":"Brenowitz WD, Nelson PT, Besser LM, Heller KB, Kukull WA. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer\u2019s disease and other cerebrovascular neuropathologic changes. Neurobiol Aging. 2015;36:2702\u20138.","journal-title":"Neurobiol Aging"},{"key":"1948_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.patter.2022.100452","volume":"3","author":"Y Ning","year":"2022","unstructured":"Ning Y, Ong MEH, Chakraborty B, Goldstein BA, Ting DSW, Vaughan R, et al. Shapley variable importance cloud for interpretable machine learning. Patterns (NY). 2022;3:100452.","journal-title":"Patterns (NY)"},{"key":"1948_CR27","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/j.neurobiolaging.2015.08.008","volume":"36","author":"L Yu","year":"2015","unstructured":"Yu L, Boyle PA, Nag S, Leurgans S, Buchman AS, Wilson RS, et al. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015;36:2946\u201353.","journal-title":"Neurobiol Aging"},{"key":"1948_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14602","volume":"21","author":"L Ma","year":"2025","unstructured":"Ma L, Wang Y, Huynh ALH, Amadoru S, Wrigley S, Yates P, et al. Exploring epidemiological risk factors for cerebral amyloid angiopathy: considerations for monoclonal antibody therapy in people with Alzheimer\u2019s disease. Alzheimers Dement. 2025;21:e14602.","journal-title":"Alzheimers Dement"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01948-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:39:04Z","timestamp":1772793544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-025-01948-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1948"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01948-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ROS, MAP, MARS studies were approved separately by the Rush University Medical Center Institutional Review Board. Written informed consent was provided to participants who signed an Anatomical Gift Act. This study involved secondary analysis of de-identified data and was approved by the Monash University Human Research Ethics Committee (Project 48297).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}